Abstract
This review discusses the clinical applications of the frozen elephant trunk procedure for patients with acute aortic dissection. Sub-analysis of the multicenter Japanese Frozenix study, J-ORCHESTRA, are presented, and recent reports of frozen elephant trunk usage for acute aortic dissection are discussed.
Keywords
Introduction
Clinical outcomes after surgery for acute aortic dissection (AAD) have been improved in recent decades. However, early outcomes in patients who undergo total arch replacement or those with preoperative dissection-related complications or comorbidities remain suboptimal. The frozen elephant trunk (FET) procedure has emerged as a means of facilitating not only distal lumen thrombosis but also easier distal aortic anastomosis during total arch replacement. Several commercially made FET grafts are currently available. In 1996, Kato and colleagues 1 first reported 10 patients who had undergone home-made stent-graft insertion in an aneurysmal descending aorta, and the true lumen in a case of dissected descending aorta. The stent-graft was constructed with a self-expanding stent anchored into the woven Dacron graft. In 2003, Karck and colleagues 2 reported 4 patients who had custom-made stent-grafts. Since then, the frozen elephant trunk procedure has become widespread, mainly in Europe, and many clinical investigations using commercially made products have been reported.3–6 In China, Sun’s group developed their own FET which is mainly used in patients with acute type A aortic dissection. 7
Current status of treatment for acute aortic dissection in databases and registries
According to a survey by the Japanese Association for Thoracic Surgery, which covers 97% of cardiac, thoracic, and esophageal procedures, the annual number of operations for acute type A aortic dissection has steadily increased. 8 Since 1984, the number of operations for AAD increased to 1022 in 1996, and to 4794 in 2017. The 30-day mortality was 26.7% in 1996, and it improved to 8.9%, and hospital mortality was 11.2% (Figure 1). 8 The yearly number of the FET prosthesis used in surgical treatment for AAD has dramatically increased since 2015 and exceeded 1000 in 2017 (Figure 2). Abe and colleagues 9 reported clinical outcomes of patients with surgically treated AAD, using the Japan Cardiovascular Surgical Database. They also reported that the number of surgically treated cases increased from 2436 in 2008–2009 to 3533 in 2014–2015, a 45% increase. Significant changes have been found in patient characteristics over time, including increasing age and rate of preoperative renal failure. Despite worsening risk factors, the unadjusted operative mortality rate for arch replacement showed a significant downward trend. The risk-adjusted mortality rate showed a downward trend both in ascending aorta or hemiarch and arch replacement. On the other hand, the Japanese Registry of All Cardiac and Vascular Diseases database has the data of patients who had medical or surgical treatment for acute type A aortic dissection. 10 Patients who had non-surgical treatment comprised 33% of 10,131 patients from April 2012 to March 2015. The early mortality of patients with medical treatment was reported to be much higher (49.7%) compared to surgical cases (11.8%). The International Registry of Acute Aortic Dissections demonstrated a similar decreasing trend in early adverse outcomes in patients who had surgery for AAD. Their 20-year experience data showed decreased surgical mortality from 25% in 1996 to 18% in 2016. 11 On the other hand, in the Society for Thoracic Surgeons data from 2004 to 2016, the early mortality after surgery for AAD has been constant at 18.9%. 12 The German Registry for Acute Aortic Dissection Type A showed early mortality of 16.9% in 2137 patients from 2006 to 2010, 13 and the Nordic Consortium for Acute Type A Aortic Dissection registry showed early mortality of 18%. 14

Annual number of operations and hospital deaths after surgery for acute aortic dissection in Japan. Pink bar: number of operations; red line: hospital mortality.

Annual number of operations and hospital deaths after frozen elephant trunk use for acute aortic dissection in Japan. Blue bar: number of operation; red line: hospital mortality.
Surgery with the frozen elephant trunk procedure in patients with acute aortic dissection
In the technique of total arch replacement, 15 the arterial return is provided by direct cannulation of the ascending aorta or right axillary artery, with return provided by an anastomosed 8-mm Dacron graft (Figure 3a). Cerebral protection is achieved using moderate hypothermic circulatory arrest combined with antegrade cerebral perfusion. The skin incision is extended to the left supraclavicular fossa, and the left subclavian artery is taped medial to the left common carotid artery. Core cooling is performed until both tympanic temperatures go down to 23°C and rectal temperature to 30°C. Total circulatory arrest is obtained with central venous pressure rising to 5 mm Hg. The heart is arrested by infusion of retrograde cardioplegia solution. The aortic cannula is removed, and the aortic arch is opened longitudinally (Figure 3b). A 12F balloon-tipped cannula is inserted into the left subclavian artery (LSCA) and the left common carotid artery (LCCA), and a 15F cannula is placed in the brachiocephalic artery from inside the arch. Antegrade cerebral perfusion is started using a single roller pump with a flow rate of 10 to 12 mL·kg−1·min−1 (Figure 3c). The perfusate temperature is kept at 23°C. The left and right radial pressures, as well as the line pressure of the balloon catheters, are monitored to keep the pressure between 30 and 50 mm Hg. Cerebral oxygen saturation is monitored bilaterally from the forehead using near-infrared spectroscopy. The arch is transected at zone II (between the LCCA and LSCA; Figure 3b). The size of the true lumen of the descending aorta is measured using a ball calliper. The LSCA is transected at its origin, and a 12F cannula is reinserted into the distal lumen. The proximal stump of the LSCA is oversewn using a buttressed 3/0 polypropylene suture (Figure 3h).

Illustrations of total arch replacement in a patient with acute aortic dissection.
The diameter of FET is determined as 90%–100% of the diameter of the descending aorta in cases of acute dissection. The length of the FET is determined by measuring the distance between the anastomosis site and the level of the aortic valve in the descending aorta, or less. A 21 mm × 12 cm Frozenix frozen elephant trunk graft (J-graft; Japan LifeLine, Tokyo, Japan) is prepared. A gentle curve is made at the stent-graft portion of the FET, to conform to the shape of the aortic arch and descending aorta. The descending aorta is filled with blood, and the FET is introduced into the true lumen of the descending aorta. The FET is deployed by pulling the sheath proximally while monitoring with transesophageal echocardiography. A non-stented portion of the FET is resected, and the FET is fixed at the descending aorta with Teflon felt reinforcement using three mattress 4/0 polypropylene sutures (Figure 3d). A 24-mm 4-branched Dacron graft is anastomosed to the stump of the descending aorta, incorporating the FET and Teflon felt, using a long 3/0 monofluorvinylydene suture. Antegrade perfusion of the lower body is slowly started through the 4th side-branch of the graft. Rewarming is then started (Figure 3f). The ascending aorta is transected 1 cm above the sinotubular junction. A 5-mm wide graft strip is placed inside the proximal lumen and fixed with 3 mattress sutures with an outer Teflon strip. A small amount of BioGlue is placed in the proximal false lumen. A continuous horizontal mattress suture is used to close the false lumen (Figure 3e). The four-branch graft is anastomosed to the ascending aorta using monofluorvinylydene suture (Figure 3f). After a de-airing procedure, the graft clamp is released, and the heart is reperfused. After making three buttons of each arch vessel, the LSCA is clamped and reconstructed to a graft branch using a 17-mm needle with 5/0 polypropylene suture (Figure 3g). The button of the LCCA is also anastomosed to a graft branch in the same manner. The balloon cannula is removed near the end of each anastomosis, and liberal backflow is used for flushing out debris. Finally, the brachiocephalic artery is clamped and anastomosed. After defibrillation and de-airing procedures, the patient is weaned off cardiopulmonary bypass (Figure 3h).
J-ORCHESTRA study
The Japan-made FET prosthesis (Frozenix) was first launched in 2014. 5 The prosthesis consists of a Dacron polyester fabric vascular prosthesis with nitinol stents affixed on the inner aspect. The main advantages of the Frozenix are easier handling and implantability, and better conformation to the curvature of the aortic arch. Since 2014, more than 12,000 prostheses have been implanted. The etiologies of the treated aortic lesions were degenerative aneurysms in 43% of patients, acute type A aortic dissection in 42%, chronic type A dissection in 3%, acute type B dissection in 2%, and chronic type B dissection in 8%.
We conducted a multicenter (41 institutions) prospective study (J-ORCHESTRA; J-Open caRdiac aortic arCH disEase replacement Surgical TheRApy Study) comparing clinical outcomes between patients who had total arch replacement with FET and patients who had total arch replacement with or without the classic free elephant trunk (TAR group). 16 The primary endpoint of this study was patient death. Secondary endpoints were cerebral complications such as stroke and temporary neurological dysfunction, spinal cord complications such as paraplegia, paraparesis, or incontinence, and aortic size in computed tomography scans during follow-up. Forty-one institutions joined in this study that included 372 patients in the FET group and 321 in the TAR group from January 2016 to March 2019. The patients were followed up for three years (Figure 4). Aneurysm lesions in patients in the FET group consisted of a degenerative aneurysm in 55%, acute or subacute (surgery from 2 weeks to 2 months from the onset) aortic dissection in 28%, chronic aortic dissecting aneurysm in 12%, and ruptured aneurysm in 5%. Clinical data of 143 patients with acute aortic dissection who had FET were analyzed. Our other study using the Japanese database from 2013 to 2018 disclosed that 12.2% of 29,486 patients who had surgery for acute aortic dissection had FET procedures.

Patient enrollment in the J-ORCHESTRA study. FET: frozen elephant trunk.
The results showed that the mean age at operation was 61 years, and male sex was predominant at 69%. Emergency (immediate, 86.7%) or urgent (within 24 h after admission, 4.2%) surgery was performed in 90% of the patients. The majority of patients had moderate hypothermia between 20°C and 30°C, and 80% of patients had antegrade cerebral perfusion. Details of the surgery are listed in Table 1. Hospital death occurred in 3 patients (2.1%) Postoperative new permanent neurological deficit occurred in 11 (7.7%) patients and temporary deficit in 8 patients (5.6%). New paraplegia occurred in 3 patients (2.1%) and paraparesis in 2 patients (1.4%). The other complications are listed in Table 2. The size of the false lumen in the descending aorta after surgery decreased significantly during follow-up (Figure 5).
Details of surgery.
CI: confidence interval.
Early outcomes.

False lumen diameter in the descending aorta. Blue line: patients with acute aortic dissection.
Reported studies
Table 3 shows a recent clinical summary of FET experiences in the surgical treatment of AAD.5–7,17–23 The aortic lesions associated with AAD included chronic aortic dissection and degenerative aneurysms. Excluding the meta-analysis, early mortality ranging from 1.4% to 17% is acceptable. The incidence of permanent stroke ranged from 2.6 to 14%, and newly developed spinal cord ischemia was noted in 1.2% to 5.1%. The occurrence of postoperative acute kidney injury ranged from 2% to 19%.
Summary of recent reports of frozen elephant trunk usage.
ACP: antegrade cerebral perfusion; AD: aortic dissection; AKI: acute kidney injury; CA: circulatory arrest; Cx: complication; ED: early death; HCA: hypothermic circulatory arrest; multi-C: multicenter study; OS: observational study; RCP: retrograde cerebral perfusion.
Discussion
The clinical advantage of FET is thought to be ease of handling the distal anastomosis in total arch replacement. This technique enables anastomosis in zone II, between the LCCA and LSCA, and can reduce the occurrence of left recurrent nerve palsy. In addition, bleeding from the distal anastomosis is seldom seen, and there is a lower incidence of leakage into the distal false lumen, resulting in positive remodelling of the distal aorta.
The Frozenix is structurally simple and very easy to handle. However, some disadvantages do exist. The line-up of the Frozenix consists of a stent length of 6 to 15 cm, with a stent diameter of 21 cm to 39 mm. The main concern in using this method is the relatively higher incidence of development of spinal cord ischemia. 18 A recent survey showed an incidence of spinal cord ischemia of 1.7% in 4600 patients. 24 The J-ORCHESTRA study on the Frozenix disclosed a 3.8% incidence of postoperative spinal cord complications. Deliberate deployment of the distal stent-graft in the descending aorta above the level of the aortic valve should be considered to prevent spinal cord complications. 18 There have been some reports regarding the occurrence of stent-graft-induced new entry, 25 but we found that its incidence using the Frozenix was quite low because the Frozenix has an internal stent skeleton. The occurrence of stent-graft-induced new entry can be alleviated by inserting the FET in a vertical position. Because the Frozenx has a central lumen to allow a guidewire to lead the stent-graft insertion, liberal usage of a guidewire from the femoral artery is recommended.
Current indications for FET usage are patients with acute type A aortic dissection who require total arch replacement. Degenerative arch aneurysm or chronic aortic dissection with suitable anatomy are relative indications for FET. A shaggy descending aorta or the presence of mega-aorta syndrome are contraindications for FET usage. It was concluded that early outcomes after total arch replacement with/without FET usage are satisfactory. The reported incidence of early death and postoperative neurological complications are acceptably low.
Footnotes
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.
